• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠癌新辅助放疗剂量的差异。

Disparities in neoadjuvant radiation dosing for treatment of rectal cancer.

机构信息

Department of Surgery, University Hospitals Research in Surgical Outcomes & Effectiveness Center (UH-RISES), University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Department of Radiation Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

出版信息

Am J Surg. 2020 Oct;220(4):987-992. doi: 10.1016/j.amjsurg.2020.01.016. Epub 2020 Jan 13.

DOI:10.1016/j.amjsurg.2020.01.016
PMID:31959352
Abstract

BACKGROUND

Certain patients are less likely to undergo appropriate cancer treatment, worsening their overall cancer survival. The purpose of this investigation was to identify factors associated with inadequate neoadjuvant radiation for rectal cancer.

METHODS

The National Cancer Database was queried for patients with locally advanced rectal cancer who received neoadjuvant radiation 2006-2014. Adequate radiation was considered to be 4,500-5,040 cGy. Demographic, hospital and clinical variables were analyzed for association with inadequate radiation.

RESULTS

The study cohort was 34,391 patients; 1,842(5.4%) received inadequate radiation. On multivariate analysis, female gender, older age, other race, government-provided insurance, lower clinical stage and rural location correlated with inadequate radiation.

CONCLUSIONS

Women were 50% less likely than men to receive correct neoadjuvant radiation dosing. Other factors including age, race, insurance, clinical stage, geographic location and neoadjuvant chemotherapy were significantly associated with radiation dosing. These factors should be evaluated to determine if they can be modified to improve outcomes.

摘要

背景

某些患者不太可能接受适当的癌症治疗,从而导致整体癌症生存率下降。本研究旨在确定与直肠癌新辅助放疗不足相关的因素。

方法

本研究检索了 2006 年至 2014 年间接受新辅助放疗的局部晚期直肠癌患者的国家癌症数据库。将 4500-5040cGy 的放疗视为充分放疗。对人口统计学、医院和临床变量进行分析,以确定与放疗不足相关的因素。

结果

本研究队列共 34391 例患者,其中 1842 例(5.4%)接受了不足的放疗。多因素分析显示,女性、年龄较大、其他种族、政府提供的保险、较低的临床分期和农村地区与放疗不足相关。

结论

女性接受正确新辅助放疗剂量的可能性比男性低 50%。其他因素,包括年龄、种族、保险、临床分期、地理位置和新辅助化疗,与放疗剂量显著相关。应评估这些因素,以确定是否可以进行调整以改善结果。

相似文献

1
Disparities in neoadjuvant radiation dosing for treatment of rectal cancer.直肠癌新辅助放疗剂量的差异。
Am J Surg. 2020 Oct;220(4):987-992. doi: 10.1016/j.amjsurg.2020.01.016. Epub 2020 Jan 13.
2
Adding Boost to Standard Neoadjuvant Radiation for Rectal Cancer Improves Likelihood of Complete Response.在标准新辅助放疗基础上添加贝伐珠单抗可提高直肠癌完全缓解率。
J Gastrointest Surg. 2020 Jul;24(7):1655-1662. doi: 10.1007/s11605-020-04594-7. Epub 2020 Apr 22.
3
Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer.局部晚期直肠癌患者新辅助放疗不完整与生存之间的关联
JAMA Surg. 2017 Jun 1;152(6):558-564. doi: 10.1001/jamasurg.2017.0010.
4
Racial and ethnic disparities in outcomes with radiation therapy for rectal adenocarcinoma.直肠癌放疗结局的种族和民族差异。
Int J Colorectal Dis. 2012 Jun;27(6):737-49. doi: 10.1007/s00384-011-1378-2. Epub 2011 Dec 10.
5
Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.直肠癌中分割新辅助放疗。
Dis Colon Rectum. 2013 Apr;56(4):422-32. doi: 10.1097/DCR.0b013e31828576c6.
6
Adjuvant radiation for rectal cancer: do we measure up to the standard of care? An epidemiologic analysis of trends over 25 years in the United States.直肠癌辅助放疗:我们是否达到了护理标准?美国25年趋势的流行病学分析。
Dis Colon Rectum. 2005 Jan;48(1):9-15. doi: 10.1007/s10350-004-0792-8.
7
Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity.直肠癌的新辅助治疗:肿瘤反应与急性毒性
Dis Colon Rectum. 2001 Apr;44(4):513-22. doi: 10.1007/BF02234323.
8
Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer.新辅助放疗或放化疗后辅助化疗对局部晚期直肠癌患者的影响。
J Cancer Res Clin Oncol. 2017 Nov;143(11):2363-2373. doi: 10.1007/s00432-017-2483-6. Epub 2017 Jul 29.
9
Neoadjuvant radiation above NCCN guidelines for rectal cancer is associated with age under 50 and early clinical stage.直肠癌新辅助放疗超出美国国立综合癌症网络(NCCN)指南与50岁以下年龄及早期临床分期相关。
Surg Endosc. 2022 May;36(5):2925-2935. doi: 10.1007/s00464-021-08585-w. Epub 2021 Jun 10.
10
Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.新辅助放化疗与局部晚期直肠癌患者生存的关系。
Colorectal Dis. 2017 Dec;19(12):1058-1066. doi: 10.1111/codi.13754.

引用本文的文献

1
Unique Considerations in Caring for Rural Patients with Rectal Cancer: A Scoping Review of the Literature from the USA and Canada.农村直肠癌患者护理中的独特考量:对美国和加拿大文献的范围综述
J Clin Med. 2025 Jun 10;14(12):4106. doi: 10.3390/jcm14124106.
2
Factors Associated with Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer.与 II 期结肠癌接受辅助化疗相关的因素。
Ann Surg Oncol. 2023 Sep;30(9):5511-5518. doi: 10.1245/s10434-023-13631-z. Epub 2023 May 30.
3
ASO Author Reflections: The Financial Impact of Out-of-Pocket Costs Among Patients Undergoing Resection for Colorectal Carcinoma.
美国骨科学会作者反思:结直肠癌切除患者自付费用的财务影响
Ann Surg Oncol. 2022 Sep;29(9):5398-5399. doi: 10.1245/s10434-022-11760-5. Epub 2022 Apr 12.
4
Evaluation of Demographics and Management of Rectal Cancer by Age Group: A Retrospective Propensity Matched Cohort Analysis of the National Cancer Database.按年龄组评估直肠癌的人口统计学特征与管理:一项基于国家癌症数据库的回顾性倾向匹配队列分析
Cureus. 2021 Nov 9;13(11):e19412. doi: 10.7759/cureus.19412. eCollection 2021 Nov.
5
Neoadjuvant radiation above NCCN guidelines for rectal cancer is associated with age under 50 and early clinical stage.直肠癌新辅助放疗超出美国国立综合癌症网络(NCCN)指南与50岁以下年龄及早期临床分期相关。
Surg Endosc. 2022 May;36(5):2925-2935. doi: 10.1007/s00464-021-08585-w. Epub 2021 Jun 10.